CLEVELAND, Feb. 23, 2015 /PRNewswire/
-- DATATRAK International, Inc. (OTCQX: DTRK), a
leader in developing cloud-based, unified
eClinical® technologies and delivering related
services for the clinical trials industry, today announced a
technology leadership role at the upcoming 2015 ACDM Conference on
18 March in Brussels.
DATATRAK will present 'Technology Trends
Transforming Clinical Trials' at 11:30am
CET and will take questions and answers following the
presentation. The presentation focuses on how mobile
technology, social media, cloud computing and big data analytics
have and will continue to affect clinical research.
"Technology continues to disrupt industries and clinical
research is no exception. What is surprising to us is the wide
acceptance of eClinical solutions that don't provide the full
benefit of technology. Those solutions require time consuming and
repetitive manual processes," said Laurence
P. Birch, Chairman and CEO, DATATRAK. "Our
unified platform leverages the power of technology to not only
eliminate these manual complexities but also deliver real-time
online insight to actively manage single or multiple
trials. That means a safer trial, better data quality, and
time and cost savings. It's time to challenge the norm in
eClinical," concluded Birch.
Join DATATRAK Thought Leaders:
- Twitter
- LinkedIn
- SlideShare
- The DATATRAK Blog
Tweet: How #technology trends are transforming #clinicaltrials
at #acdm15 http://bit.ly/1DBMWqb
About
DATATRAK International,
Inc.
DATATRAK International is a worldwide
technology and services company delivering unified
eClinical® solutions and related services for the
clinical trials industry. DATATRAK built its
multi-component, comprehensive solution on a single, unified
platform and expanded this concept to include services delivery via
DATATRAK's Clinical and Consulting Services group.
The Company delivers a complete portfolio of software products
designed to accelerate the reporting of clinical research data from
sites to sponsors and ultimately regulatory authorities, faster and
more efficiently than loosely integrated technologies. The
DATATRAK ONE® software solution,
deployed worldwide through an ASP or Enterprise Transfer offering,
supports Preclinical and Phase I - Phase IV drug and device studies
in multiple languages throughout the world. DATATRAK
is located in Cleveland, Ohio;
Bryan, Texas; Cary (RTP),
North Carolina, Chicago, Illinois; and London, England. For more information,
visit http://www.datatrak.com.
Except for the historical information contained in this press
release, the statements made in this release are forward-looking
statements. These forward-looking statements
are made based on management's expectations, assumptions, estimates
and current beliefs concerning the operations, future results and
prospects of the Company and are subject to uncertainties and
factors which are difficult to predict and, in many instances, are
beyond the control of the Company, and which could cause actual
results to differ materially from those contemplated in these
forward-looking statements. For a list of certain factors that may
cause actual results to differ materially from those contemplated
in these forward looking statements, please see the Company's
report filed with the OTCQX Market on November 13, 2014 announcing its results for the
third quarter 2014. The Company undertakes no obligation to update
publicly or revise any forward-looking statement whether as a
result of new information, future events or otherwise.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/datatrak-presenting-technology-expertise-at-acdm-300039329.html
SOURCE DATATRAK International, Inc.